EyePoint poaches medical chief from Apellis; Sandoz CFO, longtime BioNTech exec to retire

Af­ter six years as head of clin­i­cal de­vel­op­ment at Apel­lis Phar­ma­ceu­ti­cals, Ramiro Ribeiro is join­ing Eye­Point Phar­ma­ceu­ti­cals as CMO.

“The reti­nal com­mu­ni­ty is rel­a­tive­ly small, so every­body knows each oth­er,” Ribeiro told End­points News in an in­ter­view. “As soon as I start­ed to talk about Eye­Point, I got re­al­ly good feed­back from KOLs and physi­cians on its sci­en­tif­ic stan­dards and qual­i­ty of work.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.